Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Revisiting use of growth factors in myelodysplastic syndromes

    ... aberrant hematopoiesis and peripheral blood refractory cytopenias. MDS is recognized to be associated with an increased ... patients, and it should be considered for the management of refractory symptomatic cytopenias. G-CSF and EPO in combination can improve ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.

    ... but relapses are not uncommon and some patients remain refractory to this approach. Patients may require frequent blood and ... eltrombopag , were developed to treat patients with refractory immune thrombocytopenia but are now being investigated for ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes.

    ... likely to receive HMAs. Compared with patients with refractory anemia , those diagnosed with refractory anemia with excess blasts or refractory cytopenia ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Pediatric myelodysplastic syndromes: they do exist!

    ... hypocellular bone marrow and monosomy 7 . Refractory cytopenia is more typical than refractory anemia , as seen in the elderly. Its recognition and ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Unrelated cord blood transplantation in a child with very severe aplastic anemia

    ... treatment of very severe aplastic anemia (vSAA) refractory to immunosuppressive therapy (IST) in the absence of a human ... risk of graft failure. We report a patient with vSAA refractory to IST that was repeatedly complicated by bacterial infection. An ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials

    ... 5+2 +2): seven patients were classified as having refractory cytopenia with multilineage dysplasia (RCMD), nine patients with refractory anemia with excess of blasts (RAEB) type 1, 18 ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.

    ... follow-up on 67 SAA patients (44 treatment-naive and 23 refractory ) treated with high-dose cyclophosphamide. At 10 years, the ... was 58% in 44 treatment-naive SAA patients. Patients with refractory SAA fared less well after high-dose cyclophosphamide therapy; at 10 ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia

    ... with acquired severe aplastic anemia (SAA) refractory to immunosuppressive therapy and lacking HLA -matched ... as a salvage therapy for children and adolescents with refractory SAA who lack matched donors. ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes

    ... 24-month survival (especially among patients with refractory anemia or refractory anemia with excess blasts ). The magnitude of the cost of ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes

    ... bone marrow disorders characterized by chronic refractory anemia . Many patients with MDS are dependent on regular ...

    Research Article last updated 07/20/2018 - 5:15pm.